COGENT BIOSCIENCES INC (COGT) Stock Balance Sheet
NASDAQ:COGT - US19240Q2012 - Common Stock
13.05 USD
+0.11 (+0.85%)
13.05 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 127.60M | 98.17M | 53.23M | 139.90M | 219.70M | |||
| Marketable Securities | 110.25M | 188.91M | 212.48M | 119.40M | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 7.16M | 9.39M | 5.06M | 5.70M | 2.90M | |||
| Total Current Assets | 245.01M | 296.47M | 270.77M | 265.00M | 222.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 24.95M | 26.56M | 30.34M | 31.10M | 4.50M | |||
| Investments And Advances | N/A | 0.00 | 7.46M | N/A | N/A | |||
| Other Non-Current Assets | 4.86M | 4.86M | 4.86M | 4.70M | 5.00M | |||
| Total Non-Current Assets | 29.81M | 31.43M | 42.67M | 35.80M | 9.50M | |||
| TOTAL ASSETS | 274.82M | 327.90M | 313.44M | 300.80M | 232.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 40.52M | 43.32M | 27.07M | 18.90M | 10.30M | |||
| Accounts Payable | 16.63M | 12.01M | 10.65M | 5.80M | 3.50M | |||
| Other Current Liabilities | 1.27M | 373.00K | 441.00K | 2.10M | 3.30M | |||
| Total Current Liabilities | 58.42M | 55.71M | 38.17M | 26.80M | 17.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 43.95M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 17.41M | 15.90M | 17.47M | 18.20M | 800.00K | |||
| Total Non-Current Liabilities | 61.36M | 15.90M | 17.47M | 18.30M | 800.00K | |||
| TOTAL LIABILITIES | 119.78M | 71.61M | 55.63M | 45.10M | 17.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.00B | -859.48M | -603.62M | -411.20M | -271.00M | |||
| Additional Paid In Capital | 1.05B | 1.00B | 801.06M | 601.20M | 399.70M | |||
| Common Shares | 108.03M | 110.71M | 60.12M | 65.90M | 85.40M | |||
| Other Shareholders' Equity | 13.00K | 447.00K | 246.00K | -100.00K | N/A | |||
| Shares Outstanding | 113.93M | 110.46M | 86.12M | 69.90M | 43.80M | |||
| Tangible Book Value per Share | 0.41 | 1.32 | 2.30 | 2.72 | 2.94 | |||
| Total Shareholders' Equity | 155.04M | 256.29M | 257.80M | 255.70M | 214.20M | |||
| TOTAL LIABILITIES AND EQUITY | 274.82M | 327.90M | 313.44M | 300.80M | 232.10M | |||
| Statistics | ||||||||
| Debt/Equity | 0.28 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 4.19 | 5.32 | 7.09 | 9.89 | 13.02 | |||
| Return On Assets (ROA) | -74.40% | -61.30% | -49.45% | -46.62% | -31.14% | |||
| Return On Equity (ROE) | -131.89% | -78.43% | -60.12% | -54.85% | -33.74% | |||
All data in USD , ROIC based on taxRate of 0.21